Microstate-based Neurofeedback in Attention Deficit Hyperactivity Disorder Population: A Randomized Controlled Crossover Trial

Neurofeedback (NFB) therapy based on spectral neuromarkers of Attention-Deficit/Hyperactivity Disorder (ADHD) has faced challenges regarding its efficacy and replicability. In this study, we investigate whether a microstate-based EEG marker, recently implicated in ADHD, could serve as a novel target for neurofeedback. Emerging research suggests that ADHD patients often exhibit an excess of microstate D, a state characterized by fronto-central cortical activity linked to attentional functions….

via https://pubmed.ncbi.nlm.nih.gov/41326701/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20251210010904&v=2.18.0.post22+67771e2